Biocompatible Nanomaterials for Sustainable Biomedical Applications

Abstract

We explore the many ways biocompatible nanomaterials may be used in sustainable biomedical settings. Quantum dots are 10 nm in size, carbon nanotubes are 50 nm, iron oxide nanoparticles are 25 nm, gold nanoparticles are 20 nm, and silver nanoparticles are 30 nm. The physicochemical features of these nanomaterials are different from one another. These nanomaterials may encapsulate therapeutic substances, according to drug loading evaluations; for example, gold nanoparticles can hold 15 mg/g of iron oxide, 12 mg/g of silver, 18 mg/g of carbon nanotubes, 20 mg/g of carbon, and 10 mg/g of quantum dots. Nanoparticles of gold (95% vitality after 24 hours), silver (93% viability), iron oxide (97% viability), carbon nanotubes (92% viability), and quantum dots (90% viability) highlight the biocompatibility of these materials. Fluorescence intensities of 1000 AU for gold nanoparticles, 980 AU for silver nanoparticles, 1050 AU for iron oxide nanoparticles, 900 AU for carbon nanotubes, and 1100 AU for quantum dots were observed in in vivo imaging investigations, further demonstrating the potential of these nanomaterials as contrast agents. By conducting thorough assessments and analyses, this study reveals how biocompatible nanomaterials can be used to create long-term biomedical applications, such as molecular imaging and targeted drug delivery, which will improve healthcare solutions and patient outcomes.